Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.
New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose ...
Project Leader: Victor Thannickal, M.D. Idiopathic pulmonary fibrosis (IPF) is chronic, progressive lung disorder with high mortality, and limited therapeutic options. Studies performed during Cycle I ...
A UIS epidemiologist is leading a community effort to reduce lung cancer risk through radon education, free test kits and ...
Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...
This project is not being offered for the current term. Please check back next semester for updates. The research of our laboratory is focused on lung embryonic specification and especially lung ...
Core Director: Rui-Ming Liu, Ph.D. Idiopathic pulmonary fibrosis (IPF) is a most enigmatic fatal lung disorder. Although significant progress has been made in our understanding of IPF pathogenesis, ...
Please provide your email address to receive an email when new articles are posted on . Next-generation technologies and diagnostic tests offer the promise of improved cancer care, but they also ...
Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health (NIH) has been awarded to a collaboration of research teams co-led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results